Related Experiment Videos
[Percutaneous pulmonary balloon valvuloplasty in Denmark]
Ugeskrift for Laeger
|October 23, 1989
Summary
Percutaneous balloon valvuloplasty (PPB) effectively treats valvular pulmonary stenosis. This minimally invasive procedure significantly reduces pressure gradients and shows long-term safety and efficacy in patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pediatric Cardiology
Background:
- Valvular pulmonary stenosis is a significant congenital heart defect.
- Percutaneous balloon valvuloplasty (PPB) emerged as a primary treatment in 1982.
- This study presents the initial PPB outcomes in Denmark.
Purpose of the Study:
- To evaluate the efficacy and safety of the first percutaneous balloon valvuloplasty (PPB) procedures for valvular pulmonary stenosis in Denmark.
- To assess the immediate and long-term hemodynamic and clinical outcomes.
Main Methods:
- PPB was performed on 25 patients (22 children, 3 adults) with valvular pulmonary stenosis.
- Hemodynamic measurements (pressure gradients) were recorded immediately before and after the procedure.
- Follow-up assessments, including Doppler or cardiac catheterization, were conducted at >6 months post-PPB.
Main Results:
- A significant reduction in mean pulmonary valve gradient from 77 mmHg to 36 mmHg (p<0.0001) was observed immediately post-PPB.
- Over 50% gradient reduction was achieved in 68% of patients.
- Long-term follow-up (average 12 months) showed sustained gradient reduction (27 mmHg) and decreased electrocardiographic right-sided hypertrophy.
Conclusions:
- Percutaneous balloon valvuloplasty is a safe and effective treatment for valvular pulmonary stenosis.
- The procedure leads to significant and sustained hemodynamic improvement.
- PPB offers a valuable therapeutic option with minimal complications.